Hosted on MSN8mon
Tempus wins FDA nod for AI-backed heart diagnosticBased on recordings of 12-lead electrocardiogram (ECG) devices, the Tempus ECG-AF algorithm can detect the risk of a patient developing AF over the next 12 months. The company added that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback